Global Anastomosis Devices Market Trends, Applications, Analysis, Growth, and Forecast: 2018 to 2027

MarketResearch.biz delivers in-depth insights on the global anastomosis devices market in its upcoming report titled, “Global Anastomosis Devices Market Trends, Applications, Analysis, Growth, and Forecast: 2018 to 2027”. The global anastomosis devices market is estimated to register a CAGR of X.X% in terms of value during forecast period 2018–2027. The report offers in-depth insights, revenue details, and other vital information regarding the target market, and the various trends, drivers, restraints, opportunities, and threats till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global anastomosis devices market report has been segmented on the basis of product type, application, and region.

An anastomosis is a surgical connection between two tubular structure such as blood vessels or loops of infections. A surgical anastomosis can be created using suture sewn by hand, mechanical staplers and biological glues, depending on the circumstances. The anastomosis is finalized with closure of outside positioned rings and interlocks both ends of blood vessel or vascular graft prosthesis, without any gaps, to prevent leakage and eventual formation of late pseudo aneurysm.

Technological advancements such as development of anastomoses devices to mitigate the risk associated with manual anastomoses in challenging conditions and increasing demand of minimal invasive procedures for coronary artery bypass surgery are major factors driving growth of the global anastomosis devices market. In addition, use of anastomosis devices in various other surgeries such as gynecological, orthopedic, ophthalmic surgeries and various benefits of anastomoses devices such as reduced chances of vessel leakage, stenosis, and occlusion as compared to conventional procedures are other factors expected to support growth of the global anastomosis devices market.

However, presence of other therapies and substitutes is a major factor restraining growth of the global anastomosis devices market. Technological advancements such as development of sutureless anastomosis device that have various benefits such as low operation error, minimal or no damage to native vessel, and reduced turbulent flow is expected to present new opportunities in terms of revenue to players operating in the global anastomosis devices market over the forecast period.

North America market is expected to dominate in the global anastomosis devices market with higher revenue share as compared to other regional markets, owing to increasing cardiovascular, ophthalmic, and other surgeries, favorable reimbursement policies, and presence of prominent players operating in countries in this region. Europe market accounts for second-largest revenue share in the global anastomosis devices market followed by markets in Asia Pacific, Latin America and Middle East & Africa respectively. The market in Asia Pacific is projected to witness fastest growth in terms of revenue. This can be attributed to increasing government expenditure on healthcare sector and increasing R&D activities by major players in emerging economies in this region.

Global anastomosis devices market segmentation:

By Product:

• Reusable
• Disposable

By Application:

• Cardiovascular Surgeries
• Gastrointestinal surgery
• General Surgeries
• Gynecological Surgeries
• Orthopedic Surgeries
• Ophthalmic Surgeries

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

• LivaNova PLC.
• Vitalitec International Inc.
• Dextera Surgical Inc.
• Synovis Micro Alliance, Inc.
• Medtronic PLC
• Ethicon US, LLC.
• Sorin Group USA, Inc.
• MAQUET GmbH
• Guidant Group, Inc.
• Terumo Corporation